Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ENBIOSIS Nutra for Dry Eye
- Development stage
- Unknown
- Lead developer
- ENBIOSIS Biotechnology
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
ENBIOSIS Nutra for Dry Eye is an AI-designed, microbiome-based nutraceutical developed by ENBIOSIS Biotechnology. It is an oral functional food supplement intended to support ocular surface health by modulating the gut-eye axis. The product utilizes food-derived formulations to influence the gut microbiome and systemic host physiology, offering a supplemental approach to managing dry eye symptoms. Unlike traditional pharmaceutical interventions, it does not target specific molecular pathways but rather focuses on the holistic modulation of the microbiome. It has completed clinical trials and is currently market-ready as a functional food product.
- Brand names
- ENBIOSIS Nutra
- Other names
- ENBIOSIS Nutra - Dry Eye
Beyond the preview
Go deeper on ENBIOSIS Nutra for Dry Eye.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENBIOSIS Nutra for Dry Eye.